United Kingdom
The University of Manchester - Division of Infection
Pirfenidone, IDIOPATHIC PULMONARY FIBROSIS, IPF, pirfenidone solution for inhalation (AP01), ACTRN12618001838202, aerosol delivery, interstitial lung disease, forced vital capacity